14676043|t|Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
14676043|a|BACKGROUND: Tau and beta-amyloid (Abeta) are proposed diagnostic biomarkers for Alzheimer disease (AD). Previous studies report their relationship to clinical diagnoses of AD and other dementias. To understand their value as predictors of disease-specific pathology, levels determined during life must be correlated with definitive diagnoses in mixed dementia groups and cognitively normal subjects. OBJECTIVES: To correlate antemortem cerebrospinal fluid (CSF) tau and Abeta levels with definitive dementia diagnosis in a diverse group of patients; to calculate statistics for CSF tau and Abeta. DESIGN: Prospective study. SETTING: Ten clinics experienced in the diagnosis of neurodegenerative dementias. Patients One hundred six patients with dementia and 4 cognitively normal subjects with a definitive diagnosis, and 69 clinically diagnosed cognitively normal subjects. MAIN OUTCOME MEASURES: Correlation of CSF tau and Abeta with final diagnosis. RESULTS: Mean tau level was 612 pg/mL for the 74 patients with AD, 272 pg/mL for 10 patients with frontal dementia, 282 pg/mL for 3 patients with dementia with Lewy bodies, and 140 pg/mL for 73 cognitively normal control subjects. Tau was less than 334 pg/mL for 20 patients with AD. Abeta42 was reduced in patients with AD (61 fmol/mL) compared with patients with frontal dementia (133 fmol/mL) and control subjects (109 fmol/mL), but not compared with patients with dementia with Lewy bodies (14 fmol/mL) or prion disease (60 fmol/mL). CONCLUSIONS: Elevated CSF tau levels are associated with AD pathology and can help discriminate AD from other dementing disorders. However, some patients with AD have a level less than the mean +/- 2 SDs of the cognitively normal cohort.
14676043	20	23	tau	Gene	4137
14676043	97	105	dementia	Disease	MESH:D003704
14676043	129	132	Tau	Gene	4137
14676043	151	156	Abeta	Gene	351
14676043	197	214	Alzheimer disease	Disease	MESH:D000544
14676043	216	218	AD	Disease	MESH:D000544
14676043	289	291	AD	Disease	MESH:D000544
14676043	302	311	dementias	Disease	MESH:D003704
14676043	468	476	dementia	Disease	MESH:D003704
14676043	579	582	tau	Gene	4137
14676043	587	592	Abeta	Gene	351
14676043	616	624	dementia	Disease	MESH:D003704
14676043	657	665	patients	Species	9606
14676043	699	702	tau	Gene	4137
14676043	707	712	Abeta	Gene	351
14676043	794	821	neurodegenerative dementias	Disease	MESH:D019636
14676043	823	831	Patients	Species	9606
14676043	848	856	patients	Species	9606
14676043	862	870	dementia	Disease	MESH:D003704
14676043	1033	1036	tau	Gene	4137
14676043	1041	1046	Abeta	Gene	351
14676043	1083	1086	tau	Gene	4137
14676043	1118	1126	patients	Species	9606
14676043	1132	1134	AD	Disease	MESH:D000544
14676043	1153	1161	patients	Species	9606
14676043	1167	1183	frontal dementia	Disease	MESH:D003704
14676043	1201	1209	patients	Species	9606
14676043	1215	1240	dementia with Lewy bodies	Disease	MESH:D020961
14676043	1300	1303	Tau	Gene	4137
14676043	1335	1343	patients	Species	9606
14676043	1349	1351	AD	Disease	MESH:D000544
14676043	1353	1360	Abeta42	Gene	351
14676043	1376	1384	patients	Species	9606
14676043	1390	1392	AD	Disease	MESH:D000544
14676043	1420	1428	patients	Species	9606
14676043	1434	1450	frontal dementia	Disease	MESH:D003704
14676043	1523	1531	patients	Species	9606
14676043	1537	1562	dementia with Lewy bodies	Disease	MESH:D020961
14676043	1579	1592	prion disease	Disease	MESH:D017096
14676043	1633	1636	tau	Gene	4137
14676043	1664	1666	AD	Disease	MESH:D000544
14676043	1703	1705	AD	Disease	MESH:D000544
14676043	1717	1736	dementing disorders	Disease	MESH:D009358
14676043	1752	1760	patients	Species	9606
14676043	1766	1768	AD	Disease	MESH:D000544
14676043	Association	MESH:D003704	4137
14676043	Association	MESH:D000544	4137
14676043	Negative_Correlation	MESH:D000544	351

